MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.drugpo.2025.105059

Медицинская библиотека · The International journal on drug policy · 2025

Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United Kingdom.

Mitchell Holly D, Clancy India, De Angelis Daniela, Egan Conor, Harris Ross J, Hutchinson Sharon, Samartsidis Pantelis, Vickerman Peter, Ward Zoe, Yeung Alan, Zaouche Mounia, Hibbert Matthew, Emmanouil Beatrice, McAuley Andrew, Nugent Christopher, Smith Josie, Artenie Adelina, Desai Monica, Hickman Matthew, Viral Hepatitis C Elimination Modelling Working Group

СтатьяОбзорПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

To evidence elimination of hepatitis C virus (HCV), countries need to demonstrate that incidence is ≤2/100 person years in people who inject drugs (PWID). Ongoing prospective cohort studies (gold-standard method) may be too expensive and unsustainable. Here, we first summarise the utility of public health surveillance data, including bio-behavioural surveys, laboratory testing, and treatment registers with additional linkage to administrative data to monitor HCV incidence or related measures. Second, we present five modelling approaches that could be used to generate evidence for assessing progress towards elimination: 1) dynamic deterministic, 2) methods for estimating the force of infection, 3) multi-parameter evidence synthesis (MPES) with back-calculation, 4) Bayesian hierarchical, and 5) cohort multi-state. Some of these approaches can generate modelled incidence estimates based on trends in chronic HCV prevalence, while others focus on related measures such as the decline in chronic HCV prevalence, or the total number of chronic HCV infections that have been diagnosed. We propose that multiple different measures of progress are possible and together, can provide evidence on whether the UK has achieved elimination.

Для цитирования: Mitchell Holly D, Clancy India, De Angelis Daniela, Egan Conor, Harris Ross J, Hutchinson Sharon, Samartsidis Pantelis, Vickerman Peter, Ward Zoe, Yeung Alan, Zaouche Mounia, Hibbert Matthew, Emmanouil Beatrice, McAuley Andrew, Nugent Christopher, Smith Josie, Artenie Adelina, Desai Monica, Hickman Matthew, Viral Hepatitis C Elimination Modelling Working Group. Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United Kingdom.. The International journal on drug policy. 2025. DOI: 10.1016/j.drugpo.2025.105059.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.